Journal of Virus Eradication (Jul 2016)

OA2-3 BCL-2 antagonism decreases HIV replication and infected cell survival in acute in vitro infection.

N. Cummins,
A. Sainksi,
S. Natesampillai,
S. Rizza,
S. Kaufmann,
A. Badley

Affiliations

N. Cummins: Mayo Clinic, Infectious Disease, Rochester, United States
A. Sainksi: Mayo Clinic, Infectious Disease, Rochester, United States
S. Natesampillai: Mayo Clinic, Infectious Disease, Rochester, United States
S. Rizza: Mayo Clinic, Infectious Disease, Rochester, United States
S. Kaufmann: Mayo Clinic, Rochester, United States
A. Badley: Mayo Clinic, Infectious Disease, Rochester, United States

Journal volume & issue: Vol. 2
pp. 2 – 3

Abstract

No abstracts available.

Published in Journal of Virus Eradication

ISSN: 2055-6640 (Print); 2055-6659 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Science: Microbiology; Medicine: Public aspects of medicine
Website: https://www.journals.elsevier.com/journal-of-virus-eradication

About the journal